# Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)

> **NCT05751031** · — · UNKNOWN · sponsor: **Fondazione Penta UK** · enrollment: 1200 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT05751031
- **Lead sponsor:** Fondazione Penta UK
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-20
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-02-20
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2023-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05751031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05751031, "Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05751031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*